| scholarly article | Q13442814 |
| P50 | author | Maximilian Mossner | Q52904409 |
| Richard B Lock | Q61292565 | ||
| Motohiro Kato | Q40858840 | ||
| P2093 | author name string | Glenn M Marshall | |
| Wolf-Karsten Hofmann | |||
| H Phillip Koeffler | |||
| Seishi Ogawa | |||
| Daniel Nowak | |||
| Nils H Thoennissen | |||
| Ryoko Okamoto | |||
| Tadayuki Akagi | |||
| Masashi Sanada | |||
| Norihiko Kawamata | |||
| Johann C Jann | |||
| Marion Klaumünzer | |||
| Natalia L M Liem | |||
| Rachael A Papa | |||
| Verena Nowak | |||
| P2860 | cites work | Role of folylpolygutamate synthetase (FPGS) in antifolate chemotherapy; a biochemical and clinical update | Q41201968 |
| Ara-C: cellular and molecular pharmacology | Q41617108 | ||
| The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs | Q43206184 | ||
| Genetic variegation of clonal architecture and propagating cells in leukaemia | Q44426152 | ||
| Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia. | Q46170702 | ||
| Studying the genotoxicity of vincristine on human lymphocytes using comet assay, micronucleus assay and TCR gene mutation test in vitro. | Q51870778 | ||
| Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. | Q51890946 | ||
| BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros | Q57734316 | ||
| Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase | Q70718749 | ||
| Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo | Q72651598 | ||
| The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse | Q74097949 | ||
| Identification and characterization of genetic variation in the folylpolyglutamate synthase gene | Q81310207 | ||
| Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia | Q24310753 | ||
| Acute lymphoblastic leukaemia | Q24602387 | ||
| Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray | Q24650855 | ||
| Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays | Q24676798 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. | Q27852067 | ||
| Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 | ||
| A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 | ||
| Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo | Q28366064 | ||
| Vincristine revisited | Q28374641 | ||
| Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products | Q28582224 | ||
| Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia | Q29614324 | ||
| Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2 | Q33521938 | ||
| Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11) | Q34005240 | ||
| Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia | Q34095608 | ||
| Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts. | Q34221738 | ||
| Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia | Q34403931 | ||
| Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects | Q34634251 | ||
| Molecular basis for decreased folylpoly-gamma-glutamate synthetase expression in a methotrexate resistant CCRF-CEM mutant cell line | Q34652639 | ||
| Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse | Q35102275 | ||
| Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC). | Q35994964 | ||
| Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group | Q36058255 | ||
| Xenograft models for the preclinical evaluation of new therapies in acute leukemia | Q36799846 | ||
| In vivo models of childhood leukemia for preclinical drug testing | Q36855336 | ||
| Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia | Q36969782 | ||
| Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia | Q37172988 | ||
| Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. | Q37351577 | ||
| Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells | Q37878174 | ||
| Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. | Q38359462 | ||
| Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. | Q39872553 | ||
| Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. | Q40136458 | ||
| Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells | Q40209687 | ||
| A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays | Q40396914 | ||
| Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells | Q40410731 | ||
| Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies | Q40533053 | ||
| Molecular analysis of murine leukemia cell lines resistant to 5, 10-dideazatetrahydrofolate identifies several amino acids critical to the function of folylpolyglutamate synthetase | Q40873521 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphoblastic leukemia | Q18553852 |
| drug resistance | Q12147416 | ||
| xenograft | Q64148587 | ||
| P304 | page(s) | 32-43.e1-35 | |
| P577 | publication date | 2014-10-29 | |
| P1433 | published in | Experimental Hematology | Q5421109 |
| P1476 | title | Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance | |
| P478 | volume | 43 |
| Q37645045 | A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts |
| Q50145888 | Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression. |
| Q42287089 | Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML |
| Q47783708 | Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia |
| Q41781135 | Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia. |
| Q38843371 | Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia |
| Q38691997 | Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia |
| Q26799954 | Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia |
| Q64052506 | Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine |
| Q95541615 | [Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification] |
| Q53110767 | [Heterogeneity and clonal evolution in pediatric ETV6-RUNX1(+) acute lymphoblastic leukemia by quantitative multigene fluorescence in situ hybridization]. |
Search more.